SCHEMBL177936

SCHEMBL177936

SCC(Br)c1ccccn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 4/20 0.45
SLC6A4 P31645 4/20 0.45
SLC6A3 Q01959 3/20 0.45
TSHR P16473 1/20 0.44
KCNA5 P22460 5/20 0.42
KCNH2 Q12809 3/20 0.42
KCNE1 P15382 2/20 0.40
CYP2D6 P10635 2/20 0.40
NPSR1 Q6W5P4 1/20 0.39
CHRM2 P08172 3/20 0.39
SCN1A P35498 2/20 0.39
SCN2A Q99250 2/20 0.39
SCN3A Q9NY46 2/20 0.39
CYP1A2 P05177 3/20 0.38
ALDH1A1 P00352 2/20 0.38
CHRM1 P11229 2/20 0.37
DRD1 P21728 2/20 0.37
HRH1 P35367 2/20 0.37
HRH3 Q9Y5N1 2/20 0.37
LMNA P02545 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6355812 0.81 SLC6A2 (0.47) SLC6A2SLC6A4SLC6A3TSHRKCNA5
SCHEMBL506747 0.79 KCNA5 (0.50) SLC6A2SLC6A4SLC6A3TSHRKCNA5
Bromide SCHEMBL9522591 0.79 SLC6A2 (0.45) SLC6A2SLC6A4SLC6A3TSHRKCNA5
SCHEMBL29157757 0.78 SLC6A2 (0.44) SLC6A2SLC6A4SLC6A3TSHRKCNA5
SCHEMBL28588502 0.77 SLC6A2 (0.47) SLC6A2SLC6A4SLC6A3TSHRKCNA5
SCHEMBL6551622 0.76 KCNA5 (0.51) SLC6A2SLC6A4SLC6A3TSHRKCNA5
SCHEMBL177999 0.75 TSHR (0.48) SLC6A2SLC6A4SLC6A3TSHRKCNA5
SCHEMBL177672 0.75 SLC6A2 (0.45) SLC6A2SLC6A4SLC6A3TSHRKCNA5
SCHEMBL3049830 0.75 SLC6A2 (0.54) SLC6A2SLC6A4SLC6A3TSHRKCNA5
SCHEMBL29914092 0.75 SLC6A2 (0.54) SLC6A2SLC6A4SLC6A3TSHRKCNA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2390243-B1 PROCESS FOR PREPARING BISPHENOL MITSUBISHI CHEM CORP (JP) 2020-07-08 EP disclosed
US-8445731-B2 Process for producing bisphenol compound MITSUBISHI CHEMICAL CORPORATION (JP) 2013-05-21 US disclosed
US-20120010434-A1 PROCESS FOR PRODUCING BISPHENOL COMPOUND MITSUBISHI CHEMICAL CORPORATION (JP) 2012-01-12 US disclosed
EP-2390243-A1 PROCESS FOR PREPARING BISPHENOL Mitsubishi Chemical Corporation (JP) 2011-11-30 EP disclosed
US-20110256982-A1 INTERLOCK CIRCUIT FOR UTILITY VEHICLE PARK BRAKE DEERE & COMPANY 2011-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010434-A1 PROCESS FOR PRODUCING BISPHENOL COMPOUND SULT2A1, SULT1A1, PLPBP SLC6A2 2843/4885SLC6A4 1187/4885SLC6A3 2116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.